[
    {
        "molecule_name": "antibody",
        "protein_target_name": "C6",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "<10^−7",
        "unit": "M",
        "raw_mentions": "Typically, the antibody binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore BIACORE 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand and binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., bovine serum albumin (BSA), casein) other than the predetermined antigen or a closely-related antigen.\nTypically, the antibodies of the invention bind to C6 with a dissociation equilibrium constant (K<sub>D</sub>) of approximately 10<sup>−8 </sup>M or less, or 10<sup>−9 </sup>M or less, or 10<sup>−10 </sup>M or less or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "C6",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "10^−8",
        "unit": "M",
        "raw_mentions": "Typically, the antibody binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore BIACORE 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand and binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., bovine serum albumin (BSA), casein) other than the predetermined antigen or a closely-related antigen.\nTypically, the antibodies of the invention bind to C6 with a dissociation equilibrium constant (K<sub>D</sub>) of approximately 10<sup>−8 </sup>M or less, or 10<sup>−9 </sup>M or less, or 10<sup>−10 </sup>M or less or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "C6",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "10^−9",
        "unit": "M",
        "raw_mentions": "Typically, the antibody binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore BIACORE 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand and binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., bovine serum albumin (BSA), casein) other than the predetermined antigen or a closely-related antigen.\nTypically, the antibodies of the invention bind to C6 with a dissociation equilibrium constant (K<sub>D</sub>) of approximately 10<sup>−8 </sup>M or less, or 10<sup>−9 </sup>M or less, or 10<sup>−10 </sup>M or less or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "C6",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "10^−10",
        "unit": "M",
        "raw_mentions": "Typically, the antibody binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore BIACORE 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand and binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., bovine serum albumin (BSA), casein) other than the predetermined antigen or a closely-related antigen.\nTypically, the antibodies of the invention bind to C6 with a dissociation equilibrium constant (K<sub>D</sub>) of approximately 10<sup>−8 </sup>M or less, or 10<sup>−9 </sup>M or less, or 10<sup>−10 </sup>M or less or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "C6",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "<10^−8",
        "unit": "M",
        "raw_mentions": "Typically, the antibody binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore BIACORE 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand and binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., bovine serum albumin (BSA), casein) other than the predetermined antigen or a closely-related antigen.\nTypically, the antibodies of the invention bind to C6 with a dissociation equilibrium constant (K<sub>D</sub>) of approximately 10<sup>−8 </sup>M or less, or 10<sup>−9 </sup>M or less, or 10<sup>−10 </sup>M or less or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "C6",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "<10^−9",
        "unit": "M",
        "raw_mentions": "Typically, the antibody binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore BIACORE 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand and binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., bovine serum albumin (BSA), casein) other than the predetermined antigen or a closely-related antigen.\nTypically, the antibodies of the invention bind to C6 with a dissociation equilibrium constant (K<sub>D</sub>) of approximately 10<sup>−8 </sup>M or less, or 10<sup>−9 </sup>M or less, or 10<sup>−10 </sup>M or less or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "C6",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "Kd",
        "value": "<10^−10",
        "unit": "M",
        "raw_mentions": "Typically, the antibody binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 10<sup>−7 </sup>M, such as approximately less than 10<sup>−8 </sup>M, 10<sup>−9 </sup>M or 10<sup>−10 </sup>M or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore BIACORE 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand and binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., bovine serum albumin (BSA), casein) other than the predetermined antigen or a closely-related antigen.\nTypically, the antibodies of the invention bind to C6 with a dissociation equilibrium constant (K<sub>D</sub>) of approximately 10<sup>−8 </sup>M or less, or 10<sup>−9 </sup>M or less, or 10<sup>−10 </sup>M or less or even lower when determined by surface plasmon resonance (SPR) technology in a Biacore 2000 instrument using recombinant human C6 as the analyte and the antibody as the ligand."
    }
]